UNH
60
-3
DE
39
3
CI
48
-4
XOM
48
-3
TGNA
56
-3
AEE
60
-3
ECL
59
-3
HRL
39
9
FAST
61
-3
ADP
68
-4
FCX
56
2
CVS
47
2
VTR
50
-5
SRE
63
-3
CMCSA
53
-2
GWW
69
-9
ILMN
42
-3
PAYX
54
-3
TDC
73
2
AON
52
-8
UNH
60
-3
DE
39
3
CI
48
-4
XOM
48
-3
TGNA
56
-3
AEE
60
-3
ECL
59
-3
HRL
39
9
FAST
61
-3
ADP
68
-4
FCX
56
2
CVS
47
2
VTR
50
-5
SRE
63
-3
CMCSA
53
-2
GWW
69
-9
ILMN
42
-3
PAYX
54
-3
TDC
73
2
AON
52
-8
Financhill
Back

Sage Therapeutics Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
26

SAGE
Sage Therapeutics

Last Price:
5.38
Seasonality Move:
13.72%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 4.3% based on the past 10 years of stock performance.
  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $5.37. The Score for SAGE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 4.3% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
26
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
5.34

Prediction Charts

Market Cap:
328.5M
Price in USD:
5.37
Volume:
892.32K
Beta:
1.36

Technical Analysis

SMA50:
7.01
SMA100:
8.46
SMA200:
12.55
52-Wk Change:
-72.16%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 5.37 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-28 8.10 8.54 8.62 8.10
Oct-29 8.53 8.49 8.70 8.34
Oct-30 7.69 6.46 7.97 6.20
Oct-31 6.39 6.09 6.59 5.92
Nov-1 6.09 6.05 6.16 5.84
Nov-4 5.92 5.81 6.12 5.80
Nov-5 5.67 5.94 5.95 5.64
Nov-6 6.27 5.95 6.44 5.93
Nov-7 5.96 6.32 6.42 5.86
Nov-8 6.33 6.31 6.39 6.17
Nov-11 6.46 6.31 6.65 6.29
Nov-12 6.23 5.73 6.28 5.73
Nov-13 5.71 5.74 5.86 5.63
Nov-14 5.87 5.37 5.87 5.34

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.13 per share, and an increase next year of $2.22 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.